---
title: "Generic and Biosimilar Cancer Medicines"
ocid: "ocds-h6vhtk-0368ee"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0368ee"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0368ee.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0368ee.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")"
published: "2023-04-21"
---

# Generic and Biosimilar Cancer Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")  
Current stage: Award  
OCID: ocds-h6vhtk-0368ee

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0368ee)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0368ee.json)

## Summary

The procurement process is being conducted by XYZ Public Authority in the construction industry category. The current stage of the procurement is the Tender stage, with a deadline for submissions set for 31st March 2023. The opportunity is based in London, UK, providing a chance for businesses in the construction sector to bid for contracts and expand their operations.

This tender by the XYZ Public Authority in the construction industry presents a growth opportunity for firms specialising in construction services. Companies offering construction materials, project management, or architectural design are well-suited to compete in this tender. The competitive bidding process at the Tender stage allows businesses in the construction industry to showcase their capabilities and secure contracts for upcoming projects.

## Notice

This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods were separated into forty-one (41) categories, each of which is identified as a "Lot". Full details of each awarded Lot is contained in section II.2 of this Notice.

### Lot Information

Lot 1 Bendamustine Powder For Solution For Infusion

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 2 Capecitabine Tablets

Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 3 Carboplatin Injection

Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 4 Cisplatin Injection

Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 5 Cyclophosphamide Injection, Powder For Reconstitution

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 6 Cytarabine Injections

Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 7 Dacarbazine Injections

Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 8 Disodium Folinate Injection

Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 9 Docetaxel Concentrate For Solution For Infusion

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 10 Doxorubicin Hydrochloride Injections

Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 11 Fluorouracil 25MG/ML Injection

Supply of Fluorouracil 25MG/ML Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 12 Fluorouracil 50MG/ML Injection

Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 15 Gemcitabine Powder For Solution For Infusion Vials

Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 16 Idarubicin Hydrochlioride Injection Powder For Reconstitution

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 17 Ifosfamide Injection Powder For Reconstitution

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 18 Irinotecan Hydrochloride Injection

Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 19 Lanreotide Injection Prefilled Syringes

Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 20 Methotrexate Without Preservatives Injection

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 21 Methotrexate Oral Solution

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 22 Mitomycin Injection Powder For Reconstitution

Supply of Mitomycin Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 23 Oxaliplatin Vial Solution

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 24 Paclitaxel Concentrate For Intravenous Infusion

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 25 Temozolomide Capsules

Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 26 Vincristine Without Preservatives Injection

Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 27 Vinorelbine Injection

Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 28 Aprepitant Capsules

Supply of Aprepitant Capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 29 Topotecan Capsules

Supply of Topotecan Capsules to NHS Scotland. Each product line within this Lot will be grouped together and awarded to a single Framework Participant. Full details of Goods and volumes can be found within the ITT documents.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 30 Topotecan Concentrate For Solution For Infusion

Supply of Topotecan Concentrate For Solution For Infusion to NHS Scotland. Each product line within this Lot will be grouped together and awarded to a single Framework Participant. Full details of Goods and volumes can be found within the ITT documents

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 31 Octreotide Injection

Supply of Octreotide Injection. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 32 Filgrastim Pre-Filled Syringe

Supply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 33 Pemetrexed Powder For Solution For Infusion Vials

Supply of Pemetrexed Powder For Solution For Infusion Vials in various presentations to NHS Scotland. The Authority has awarded this Lot as a single-supplier framework.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials

Supply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 35 Octreotide Vials Long Acting (Excluding Homecare)

Supply of Octreotide Vials Long Acting (Excluding Homecare) to NHS Scotland. The Authority intends awarding each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 3 Suppliers will be awarded.

Renewal: he Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 36 Octreotide Vials Long Acting (Including Homecare)

Supply of Octreotide Vials Long Acting (Including Homecare) to NHS Scotland. The Authority intends awarding each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 3 Suppliers will be awarded. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 37 Etoposide Injection

Supply of Etoposide Injection to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework award

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 38 Dasatinib Tablets

Supply of Dasatinib Tablets to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement to 2 framework participants.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines

Supply of a number of Generic & Biosimilar Medicines including bevacizumab solution for infusion, doxorubicin liposomal solution for infusion, rituximab solution for infusion, trastuzumab powder for solution for infusion, sorafenib tablets and thalidomide capsules to NHS Scotland. Each product line has been treated as an individual Lot and awarded as a unranked multi-supplier award

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 40 Idarubicin Hydrochloride Solution for Infusion

Supply of Idarubicin Hydrochloride Solution for Infusion. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 41 Single Supplier Generic Medicines

Supply of a range of generic cancer medicines to NHS Scotland. Each product line has been treated as an individual Lot and awarded to a single Framework Participant.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/011419-2023 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 21 Apr 2023 |
| Submission deadline | 17 Oct 2022 |
| Future notice date | Not specified |
| Award date | 23 Dec 2022 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £59,145,973 |
| Lots value | £59,145,972 |
| Awards value | Not specified |
| Contracts value | £33,350,281 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Active, Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 29 |
| Supplier names | ACCORD-UK; ASPEN PHARMACARE; BAXTER HEALTHCARE; BAYER; CELLTRION HEALTHCARE UNITED KINGDOM; CHUGAI PHARMA; CONSILIENT HEALTH; DR REDDY'S LABORATORIES (UK; FLEXIPHARM AUSTRADING; FRESENIUS KABI; GLENMARK PHARMACEUTICALS EUROPE; INTRAPHARM LABORATORIES; KENT PHARMACEUTICALS; MARTINDALE PHARMA; MEDAC PHARMA; MERCURY PHARMA GROUP; MORNINGSIDE PHARMACEUTICALS; NEON HEALTHCARE; ORGANON PHARMACEUTICAL; PFIZER; RANBAXY (UK; ROCHE PRODUCTS; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; TEVA; THORNTON & ROSS; VIATRIS UK HEALTHCARE; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 21 Apr 2023 at 07:53 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/011419-2023
- 16 Sep 2022 at 07:41 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/025989-2022

## Notice URLs

- http://www.nhsscotlandprocurement.scot.nhs.uk/
- http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000705779
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
- https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0368ee. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0368ee.json.